吃瓜不打烊

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Healthcare Helpline
    • 吃瓜不打烊 Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • Common Ground
    • Diagnosis: Debt
    • The Body Shops
    • Priced Out
    • Guns, Race, and Profit
    • Broken Rehab
    • Dead Zone
    • Denied
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Medicare Advantage Billing Probe
  • School Vaccine Mandates
  • Weight Loss Drugs Coverage
  • Opioid Settlement Money
  • Abortion Pill Access

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, Jul 23 2024

Full Issue

Robitussin Maker Will Stop Saying Medicine Is 'Non-Drowsy'

A consumer lawsuit had alleged the cough and flu medicines did actually cause drowsiness despite the claim on the bottle. Meanwhile, J&J is nearing a deal on an $8 billion talc settlement.

The maker of Robitussin settled a consumer lawsuit that claimed its "non-drowsy" cough and flu medicine causes drowsiness, agreeing to pay $4.5 million and remove the "non-drowsy" claim from its packaging and marketing. (Stempel, 7/22)

Johnson & Johnson is closing in on one of the largest settlements of mass-tort lawsuits in history. Its strategy is to divide and conquer the trial lawyers. The healthcare-products company is nearing a resolution of the long-running lawsuits over its talc products, offering a settlement to roughly 100,000 women who allege the company鈥檚 iconic baby powder caused them to develop gynecological cancers. If J&J wins enough of their support, it will try to use a bankruptcy filing to carry out its settlement plan, worth roughly $8 billion over time. (Scurria, Mulvaney and Gladstone, 7/23)

On marijuana 鈥

The Biden administration鈥檚 proposal to loosen federal restrictions on marijuana is dividing some of the nation鈥檚 top medical professionals. The nation鈥檚 largest and most powerful doctors group, the American Medical Association, has raised multiple concerns with the move, which is known as rescheduling. (Florko, 7/23)

Women who use marijuana before they learn of their pregnancy are at higher risk for potentially life-threatening complications like preeclampsia, a new study finds. (LaMotte, 7/22)

In other pharmaceutical news 鈥

吃瓜不打烊: Why Millions Are Trying FDA-Authorized Alternatives To Big Pharma鈥檚 Weight Loss Drugs

Pharmacist Mark Mikhael has lost 50 pounds over the past 12 months. He no longer has diabetes and finds himself 鈥渁t my ideal body weight,鈥 with his cholesterol below 200 for the first time in 20 years. 鈥淚 feel fantastic,鈥 he said. Like millions of others, Mikhael credits the new class of weight loss drugs. But he isn鈥檛 using brand-name Wegovy or Zepbound. Mikhael, CEO of Orlando, Florida-based Olympia Pharmaceuticals, has been getting by with his own supply: injecting himself with copies of the drugs formulated by his company. (Allen, 7/23)

Swallowing a handful of pills is a daily ritual for many people, from young adults coping with anxiety to older adults managing chronic conditions. Overall, 13% of people in the U.S. take five or more prescription drugs. For those 65 and older, that number is 42%. If you鈥檙e taking multiple meds, it鈥檚 smart to be aware of potential problems. One pill can lead to a side effect, leading to another pill and another side effect in what experts call a 鈥減rescribing cascade.鈥 (Johnson, 7/22)

There鈥檚 a new contender for song of the summer out now, and it comes from none other than diabetes tech maker Insulet. Insulet, maker of the Omnipod series of insulin pumps, has released 鈥淭he Pod Drop (Pod Change Theme Song),鈥 an undeniably catchy tune made solely from the sounds of an Omnipod 5 insulin pod change. Available now on popular streaming services, 鈥淭he Pod Drop鈥 was made by YouTuber and musician Andrew Huang, well known for his 鈥淪ong Challenge鈥 series of videos making music out of foods, toys and other random, non-instrument items. (Park, 7/22)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, July 31
  • Thursday, July 30
  • Wednesday, July 29
  • Tuesday, July 28
  • Monday, July 27
  • Friday, July 24
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • 吃瓜不打烊
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

漏 2026 KFF